Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene

MeSH terms

• Amino Acid Substitution
• Blood Glucose / metabolism
• Child
• Diabetes Mellitus / blood
• Diabetes Mellitus / drug therapy*
• Diabetes Mellitus / genetics
• Humans
• Hypoglycemic Agents / therapeutic use
• Infant
• Infant, Newborn
• Infant, Newborn, Diseases / drug therapy
• Infant, Newborn, Diseases / genetics
• Infant, Newborn, Diseases / metabolism
• Insulin / therapeutic use*
• Mutation*
• Potassium Channels, Inwardly Rectifying / genetics*
• Sulfonylurea Compounds / therapeutic use*
• Treatment Outcome